- Oventus Medical (OVN) has signed new contracts with U.S.-based national durable medical equipment (DME) supplier Connect DME and Australian fatigue risk management group Circadian Australia
- The contract is for three years and will automatically extended for a further three years unless either party terminates the deal
- Oventus has also signed a distribution agreement with Circadian Australia, a leader in fatigue risk managemen
- Through the first agreement, Oventus will make its technology available to Connect DME’s customers
- Meanwhile, Oventus will also provide its sleep treatment platform to Circadian’s clients across high-risk areas such as mining, aviation and oil and gas
- On market close, Oventus is down 2.50 per cent and is trading at 19.5 cents per share
